drugset / Trial / NCT03208257
Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2
NaSingle-groupOpen-labelTreatment
Summary
Septic shock is a common syndrome caused by the body's response to an infection. Septic shock is responsible for 10% of all ICU admissions and 30% of ICU deaths. Use of "beta blocker" medications may improve outcomes after septic shock. This pilot study evaluates protocols to infuse the beta blocker esmolol in patients with septic shock.
Timeline
- Start
- 2017-08-07
- Primary completion
- 2020-12
- Completion
- 2021-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | 10 ug/kg | Intravenous |
| Subject | Esmolol | Other / unclassified | 40 ug/kg | Intravenous |